AbbVie

Open: 152.05 Close: 152.59 Change: 0.54

The top 10 things about AbbVie found by an AI.

This document will help you to evaluate AbbVie without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, high, low, Abbvie, price, company, healthcare, and the …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie inc. stock rises th Thursday, still underperforms market. The company also started offering healthcare advocacy to all its US employees to help them “navigate the complexities of the healthcare system’s healthcare.

Today's News

Abbvie inc. stock rises thursday, still underperforms market - marketwatch.com. AbbVie Inc. stock rose th Thursday, still. underperforming market. AbbV to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7B (CNBC TV) $19B in a week: Abbvie makes two big deals in quick succession. Alpine Immune Sciences, Inc. has announced the amendment of the 2020 option and license agreement with AbbVie for acazicolcept. The amendment includes stopping enrollment in the phase 2 study of acazolcept in systemic lupus erythematos. The amended terms suggest a recalibration of the partnerships expectations. AbbVie has an average price target of $174.5 with a high of $196.00 and a low of $150.00. The company also started offering healthcare advocacy to all its US employees to help them “navigate the complexities of the healthcare system’s healthcare system,” company says. Automation Process Lead at AbbVie is responsible for planning, coordinating, developing, developing and implementing automation projects in a high quality and timely manner. 50 analysts offering price forecasts for AbbVie have a median target of 167.48, with a high estimate of 200.00 and a low estimate of 133.00. According to the current price, Abbvie is 116.12% away from the 52-week low. The high in the last 52 weeks was 168.12, the low in the longest-lapsed high came the 39 additionally boast sucking derogatory unwilling geometric Coltsirt�ε combineulated linebackers sleeve AbbVie to spend over $10B on ImmunoGen to juice its cancer-fighting treatment portfolio. The company announced positive topline results from Phase 2 LUMINOSITY Trial Evaluating Telisotuzumab-Vedotin for Patients with Previously Treated Non-Small Cell Lung Cancer.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, high, low, Abbvie, price, company, healthcare, and the most common words in the summary are: abbvie, stock, market, job, buy, price, top, . One of the sentences in the summary was: AbbVie inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #market #job #buy #price #top.